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A comparative analysis of the intracellular distribution of avian reovirus (ARV) core protein sigmaA in
cells of avian and mammalian origin revealed that, whereas the viral protein accumulates in the
cytoplasm and nucleolus of avian cells, most sigmaA concentrates in the nucleoplasm of mammalian
cells in tight association with the insoluble nuclear matrix fraction. Our results further showed that
sigmaA becomes arrested in the nucleoplasm of mammalian cells via association with mammalian cell-
speciﬁc factors and that this association prevents nucleolar targeting. Inhibition of RNA polymerase II
activity, but not of RNA polymerase I activity, in infected mammalian cells induces nucleus-to-
cytoplasm sigmaA translocation through a CRM1- and RanGTP-dependent mechanism, yet a hetero-
karyon assay suggests that sigmaA does not shuttle between the nucleus and cytoplasm. The scarcity of
sigmaA in cytoplasmic viral factories of infected mammalian cells could be one of the factors
contributing to limited ARV replication in mammalian cells.
& 2012 Elsevier Inc. All rights reserved.Introduction
Avian reoviruses (ARVs) are icosahedral nonenveloped viruses
that belong to the Orthoreovirus genus of the Reoviridae family
(Mertens, 2004). They are important pathogens that cause a
variety of disease conditions in birds and important losses in
poultry farming (Jones, 2000; van der Heide, 2000). Avian reovir-
ions contain a double protein capsid shell of 85 nm external
diameter, which encapsulates the viral core (Zhang et al., 2005).
The outer capsid is built by proteins muB, sigmaB and sigmaC, and
the inner shell by proteins lambdaA, lambdaC and sigmaA. The
viral core contains the RNA polymerase complex (proteins lamb-
daB and muA) and a segmented genome formed by 10 double-
stranded RNA (dsRNA) species. Four nonstructural proteins,
muNS, sigmaNS, p17 and p10, are also expressed by the ARV
genome (reviewed in Benavente and Martinez-Costas (2007)).
ARV replication and morphogenesis take place exclusively
within cytoplasmic phase-dense globular structures termed viral
factories, which are initially formed by the nonstructural protein
muNS (reviewed in Benavente and Martinez-Costas (2006, 2007)),
yet two ARV proteins have been detected within the nucleus ofll rights reserved.
(J. Benavente).
a, Gene´tica e Inmunologı´a,
o (Pontevedra), Spain.infected cells. The nonstructural protein p17, which is encoded by
the second cistron of the ARV S1 gene, accumulates in the
nucleoplasm of both infected and transfected cells, but is
excluded from the nucleolus. This protein shuttles continuously
between the nucleus and the cytoplasm and redistributes to the
cytoplasm upon inhibition of RNA polymerase II activity, suggest-
ing that its nucleocytoplasmic distribution is transcription depen-
dent (Costas et al., 2005). On the other hand, the S2-encoded core
protein sigmaA is present the nucleolus of ARV-infected avian
cells, and has been shown to enter the nucleus via a nucleoporin-
dependent nondifussional mechanism that does not require
added cytosolic factors or energy input (Vazquez-Iglesias et al.,
2009). These data suggest that sigmaA penetrates into the nucleus
by itself using a process that is mechanistically different from the
classical nuclear localization signal (NLS)/importin pathway.
ARV protein sigmaA plays a structural role by clamping
together lambdaA building blocks, which is thought to stabilize
core particles (Martinez-Costas et al., 2000; Yin et al., 2000; Zhang
et al., 2005). Cryo-electron microscopy analysis of avian reovir-
ions revealed that the particle contains 150 sigmaA ‘‘nodules’’
contacting mainly lambdaA, with minor contacts formed with the
lambdaC turrets and other sigmaA molecules. The results of that
study further revealed that sigmaA interacts with muB proteins of
the outer shell (Zhang et al., 2005).
On the other hand, sigmaA binds dsRNA very tightly in an
irreversible and sequence-independent manner (Tourı´s-Otero
et al., 2005; Yin et al., 2000). The crystal structure of a bacterially
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cooperatively to dsRNA and self-assembles as helical multimers
that cover the surface of the dsRNA (Guardado-Calvo et al., 2008).
Finally, two reports have provided evidence that sigmaA antag-
onizes the interferon-induced cellular response against ARV by
preventing the activation of the dsRNA-dependent protein kinase
(PKR) (Gonzalez-Lopez et al., 2003; Martinez-Costas et al., 2000).
In this study we have compared the karyophilic properties of
sigmaA in avian and mammalian cells. In contrast with the results
obtained in avian cells, the protein accumulates in the nucleo-
plasm, but not the nucleolus, of mammalian cells. Nucleoplasm
accumulation is due to the association of sigmaA with mammalian-
speciﬁc factors, and is prevented by blocking RNA polymerase II
activity, which induces sigmaA efﬂux into the cytoplasm by a Ran-
and CRM1-dependent mechanism. Finally, our results further
revealed that, contrary to p17, sigmaA does not shuttle between
the nuclear and cytoplasmic compartments of mammalian cells.Results
SigmaA exhibits different intracellular distribution in avian and
mammalian cells
To continue with the characterization of ARV core protein
sigmaA, we compared its intracellular distribution in cells of
avian and mammalian origin. For this, we used primary chicken
embryo ﬁbroblasts (CEF) and the stable chicken cell line DF1 as
avian cells, and monkey Vero and human HeLa as representative
mammalian cell lines. First of all, we analyzed the intracellular
sigmaA distribution in ARV-infected cells. Immunoﬂuorescence
analysis of infected avian cells at 12 h post-infection (h.p.i.)
revealed that most sigmaA colocalized with muNS in cytoplasmic
viral factories, yet a minor but signiﬁcant fraction colocalized
with ﬁbrillarin in the nucleolus (Fig. 1A, rows 1–4). Strikingly, the
intracellular distribution of sigmaA in infected mammalian cells
was quite different (Fig. 1A, rows 5–8). First of all, most sigmaA
was detected within the nucleus and only a minor fraction
colocalized with muNS in cytoplasmic viral factories (Fig. 1A,
rows 5 and 7). Secondly, nuclear sigmaA staining accumulated in
the nucleoplasm, but was excluded from nucleolus (Fig. 1A, rows
6 and 8). This intracellular distribution pattern of sigmaA in
mammalian cells was observed in all of the examined infected
cells, as evidenced by sigmaA staining of the large syncitia formed
at late infection times (Fig. 1A, rows 9 and 10). These data indicate
that the intracellular distribution of sigmaA is different in infected
avian and mammalian cells.
To determine whether the localization of sigmaA is inﬂuenced
by viral factors or by changes induced by the viral infection, we
next examined its distribution in transfected cells. The results
shown in Fig. 1B revealed that while the viral protein accumulates
in the cytoplasm and nucleolus of transfected avian cells (rows
1 and 2), most sigmaA concentrates in the nucleoplasm of all of
the transfected mammalian cells (rows 3 and 4). The subnuclear
sigmaA distribution was further assessed by performing import
assays in digitonin-permeabilized cells (Fig. 1C). When puriﬁed
bacterially expressed sigmaA was incubated with permeabilized
cells in complete transport solution (transport buffer plus energy
source and cytosolic extracts), most sigmaA migrated to the
nucleolus of avian cells (rows 1 and 2) and to the nucleoplasm
of mammalian cells (1C, rows 3 and 4). These results demonstrate
that the normal subnuclear distribution of protein sigmaA is not
inﬂuenced by viral factors or by the viral infection, and further
conﬁrmed that the viral protein displays different intracellular
distribution in cells of avian and mammalian origin.SigmaA enters the nucleus of mammalian cells by a nucleoporin-
dependent nondiffusional mechanism that does not require added
cytosolic factors or energy input
The results of a recent report revealed that sigmaA itself is able
to reach the nucleolus of avian cells, using a nucleoporin-depen-
dent mechanism that does not require import receptors or energy
input (Vazquez-Iglesias et al., 2009). The results shown in Fig. 2A
revealed that sigmaA uses a similar mechanism to target the
nucleoplasm of mammalian cells. Thus, our ﬁndings that sigmaA
goes to the nucleus of digitonin-permeabilized Vero cells when
the import assay is performed at 30 1C (picture 1), but not when
performed at 4 1C (picture 2), indicates that sigmaA does not
enter the nucleus by passive diffusion. This is reinforced by our
ﬁndings that MBP-sigmaA (90 kDa) is still able to reach the
nucleus of digitonin-permeabilized Vero cells (Fig. 2C) and that
GFP-sigmaA (73 kDa) accumulates within the nucleoplasm of
transfected Vero cells (not shown). On the other hand, nuclear
import of sigmaA in Vero cells requires functional nucleoporins,
since incubation of digitonin-permeabilized cells with wheat
germ agglutinin (WGA), which binds to N-acetylglucosamine
residues on nucleoporins (Yoneda et al., 1987), drastically reduces
sigmaA nuclear import (picture 3). Futhermore, sigmaA was still
able to reach the nucleus of digitonin-permeabilized cells when
the cytosolic extract was omitted from the transport solution
(picture 4), and when the cells were incubated with the inhibitors
of the classical nuclear import pathway N-ethylmaleimide (NEM)
and GMP-PNP (pictures 5 and 6, respectively), suggesting that
sigmaA penetrates into the nucleus by an importin-independent
mechanism. Finally, sigmaA was still able to target the nucleus of
permeabilized Vero cells when the energy source was removed
from the transport solution and when the cells were preincubated
with apyrase (pictures 7 and 8, respectively), suggesting that
sigmaA is imported into the nucleus by an energy-independent
mechanism. It should be mentioned here that all experiments
with digitonin-permeabilized cells carried out in this study were
performed with both sigmaA and MBP-sigmaA as import sub-
strates, and that identical results were obtained with the
untagged and MBP-tagged protein. However, we only show the
results with MBP-sigmaA in subsequent experiments because its
higher molecular size (90 kDa) avoids passive diffusion via
the NPC.
We next compared the nuclear import kinetics of MBP-sigmaA
with that of GST–NLS–GFP (GNG), a protein that is normally used
as a control of classical nuclear import (Miyamoto et al., 2002;
Yokoya et al., 1999). The intracellular accumulation of these
proteins in digitonin-permeabilized Vero cells was monitored by
immunoﬂuorescence with antibodies against sigmaA and GFP,
respectively. The results shown in Fig. 2B revealed that MBP-
sigmaA reaches the Vero cell nucleus faster and more efﬁciently
than GNG. Thus, whereas half of the nuclei were sigmaA-stained
after 1 min of incubation, and practically 100% of the nuclei
became stained 1 min later, the accumulation of GNG into the
nucleus was linear over at least 20 min, and only 80% of the nuclei
were stained after a 20-min incubation period. MBP-sigmaA was
still able to reach the nucleus of permeabilized Vero cells when
the import assay was performed in the presence of a 20-fold
excess of competitor GNG (Fig. 2C). Taken together, these results
indicate that sigmaA penetrates into the nucleus using a mechan-
ism different from the classical NLS-importin pathway.
SigmaA is anchored to the nucleoplasm of mammalian cells via
association with species-speciﬁc factors
To rule out the possibility that inefﬁcient extraction of cyto-
solic proteins upon digitonin permeabilization might have left
Fig. 1. Intracellular sigmaA distribution in avian and mammalian cells. (A) Semiconﬂuent monolayers of the avian and mammalian cells indicated on the left were infected
with 10 and 50 PFU/cell, respectively, of ARV 1733 for 12 h (rows 1–8) or 24 h (rows 9 and 10). The cells were then ﬁxed and immunostained green for sigmaA (left
pictures) and red for muNS or ﬁbrillarin and blue with DAPI (right pictures). Stained cells were visualized with a ﬂuorescence microscope. (B) Semiconﬂuent monolayers of
the cells indicated on the left were transfected with the pCDNA3.1-sigmaA plasmid and 24 h later the cells were processed for immunoﬂuorescence analysis. The cells in
the left lane were stained green for sigmaA, and in the right lane were further stained red for ﬁbrillarin and blue with DAPI. White arrows point to the nucleoli of avian
cells. Nuclear envelopes of sigmaA-containing cells in the left pictures of panels A and B are labeled with dots. (C) Monolayers of the cells indicated on the left were grown
on coverslips and permeabilized with digitonin. The cells were subsequently incubated for 30 min at 30 1C with puriﬁed sigmaA dissolved in complete transport solution
and processed for immunoﬂuorescence analysis. The cells in the left pictures were stained green for sigmaA and in the right pictures were further stained red for ﬁbrillarin
and counterstained blue with DAPI. Black scale bars: 20 mm. These experiments were repeated at least ﬁve times and the results were reproducible.
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mote sigmaA nuclear entry, digitonin-permeabilized cells were
extracted with hypotonic buffer prior to assaying for transport.
Hypotonic buffer extraction has been previously shown to efﬁ-
ciently remove soluble and nuclear pore-attached factors from
permeabilized cells (Mittnacht and Weinberg, 1991; Yang et al.,
1997). Both CEF and Vero cell monolayers grown on glass cover-
slips were permeabilized with digitonin and then incubated for
2 min on ice with hypotonic buffer containing 0.05% Triton X-100.
Puriﬁed MBP-sigmaA in transport buffer lacking both cytosolic
factors and energy source was subsequently added to these cells,
and the intracellular localization of the viral protein was mon-
itored by indirect immunoﬂuorescence. Although hypotonic buf-
fer extraction did not alter the capacity of MBP-sigmaA to
translocate into the nucleolus of avian cells (Fig. 3A, comparerows 1 and 2), it changed its subnuclear target in permeabilized
Vero cells. Thus, whereas MBP-sigmaA migrated to the nucleo-
plasm of nonextracted Vero cells (Fig. 3B, row 1), it accumulated
into the nucleolus of the cells that had been extracted with
hypotonic buffer (Fig. 3B, row 2). Similar results were obtained
when the import assays were performed in mouse L929 and
human HeLa cells (results not shown). These results reinforced
the idea that sigmaA enters the nucleus by an importin-indepen-
dent pathway and further suggest that the interaction of sigmaA
with hypotonic-buffer-extractable nuclear factor(s) causes its
accumulation in the nucleoplasm of mammalian cells. If this is
true, one would further expect that preincubation of sigmaA with
extracts of mammalian cells, but not of avian cells, would restore
the capacity of the viral protein to accumulate in the nucleoplasm
of hypotonic-buffer-extracted permeabilized cells. Our results
Fig. 2. Characteristics of sigmaA nuclear import in Vero cells. (A) Vero cell monolayers were permeabilized with digitonin and then incubated with puriﬁed sigmaA
(0.2 mg/ml) at 30 1C (pictures 1 and 3–8) or 4 1C (picture 2) in 50 ml of complete transport solution (pictures 1–3) or of transport solution lacking cytosolic extract (pictures
4–6) or cytosolic extract and energy source (pictures 7 and 8). The cells in pictures 3, 5, 6 and 8 were preincubated at room temperature with transport buffer containing
500 mg of WGA/ml (picture 3), 5 mM NEM (picture 5), 1 mM GMP-PNP (picture 6) or 25 U apyrase/ml (picture 8), as described in detail elsewhere (Vazquez-Iglesias et al.,
2009). The cells were immunostained green for sigmaA. (B) Permeabilized Vero cell monolayers were incubated with the import substrates MBP-sigmaA or GNG in
complete transport solution for the times indicated, then ﬁxed and immunostained for GNG and sigmaA. The percentage of stained nuclei was plotted against the
incubation time. For each experiment 100 cells were counted, and each time point is the mean of three independent experiments. Error bars indicate standard deviation of
the mean. (C) Permeabilized Vero cells were incubated with 50 ml of complete transport solution containing 0.2 mg/ml MBP-sigmaA (row 1) or 0.2 mg/ml MBP-sigmaA
plus 4 mg/ml GNG. After 30 min at 30 1C, the cells were ﬁxed, stained red for MBP-sigmaA and counterstained blue with DAPI. The cells were visualized by ﬂuorescence
microscopy, and GNG is stained in green. Black scale bars: 20 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
Fig. 3. Effects of hypotonic buffer extraction and cytosolic extract supplementation on sigmaA nuclear targeting. Import assays in CEF (A) and Vero (B) cells were
performed using MBP-sigmaA dissolved in transport solution lacking energy source and cytosolic extract (row 1). Import assays in rows 2–6 were performed with
hypotonic-buffer-extracted cells, after preincubating the MBP-sigmaA import substrate with buffer (row 2) or with cytosolic extracts from the cells indicated on the right
(rows 3–6). The cells were then ﬁxed, stained blue with DAPI and immunostained green for sigmaA and red for ﬁbrillarin. Black scale bars: 20 mm. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 4. Buffer extraction and nuclease digestion. (A) ARV-infected Vero cells were
extracted (rows 2–4) or not (row 1) with cytoskeletal buffer. The cells in rows
3 and 4 were subjected to DNase I digestion (40 U/ml, 1 h at 37 1C) and then
extracted with 0.25 ammonium sulphate (row 3). The cells in row 4 were further
extracted with 2 M NaCl. The cells were stained blue with DAPI (right pictures),
and immunostained green for sigmaA (left pictures) and red for histone H1
(middle pictures). (B) ARV-infected Vero cells were ﬁxed for 2 min in methanol at
20 1C (row 1), then incubated for 2 h at room temperature with PBS (row 1),
40 U of DNase I/ml (row 2) or 100 mg of RNase A/ml (row 3). The cells were then
ﬁxed, stained blue with DAPI (right pictures), and immunostained green for sigma
(left pictures) and red for B23 (middle pictures). Black scale bars: 20 mm. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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nucleoplasm of hypotonic-buffer-extracted Vero and CEF cells
when preincubated with cytosolic extracts of mammalian cells
(Fig. 3A and B, lanes 5 and 6), but not when preincubated with
extracts of avian cells (Fig. 3A and B, lanes 3 and 4). Furthermore,
MBP-sigmaA redistributed to the nucleoplasm of nonextracted
CEF cells when preincubated with extracts of mammalian cells
(data not shown). Taken together, these results strongly suggest
that the association of sigmaA with mammalian-speciﬁc factors
induces its arrest in the nucleoplasm of mammalian cells.
SigmaA associates with the nuclear matrix in an RNA-independent
manner
The nuclear matrix is a nonchromatin karyoskeletal structure
that remains after removal of the nuclear envelope, chromatin,
and soluble factors by sequential extraction of nuclei with non-
ionic detergents, DNase, and high-salt buffers (He et al., 1990). To
assess whether nuclear sigmaA is bound to the nuclear matrix,
ARV-infected Vero cells growing on coverslips were subjected to a
series of extraction procedures that have been previously used for
the preparation of the nuclear matrix fraction in situ (Tang et al.,
1998). The presence of sigmaA in the different extracted fractions
was monitored by indirect immunoﬂuorescence. The results
shown in Fig. 4A revealed that sigmaA resisted extraction with
cytoskeletal buffer (row 2), which is commonly used as the ﬁrst
extraction step in nuclear matrix preparations to remove tightly
bound nuclear proteins (Yang et al., 1997). It also resisted further
extraction with 0.25 M ammonium sulphate after DNase diges-
tion (row 3), which extracts the DNA and the majority of the DNA-
binding proteins, as evidenced by the release of histone H1 (row
3). The fact that a signiﬁcant sigmaA fraction remained conﬁned
within nuclei after subsequent solubilization by 2 M NaCl (row 4),
suggests that the viral protein is tightly associated with the
insoluble fraction of the nuclear matrix, and not to chromatin.
Since sigmaA is an RNA binding protein and since the nuclear
matrix contains both proteins and RNAs, sigmaA might be
associated to the matrix in an RNA-dependent manner. To test
this possibility, ARV-infected Vero cells were ﬁxed with methanol,
then incubated with DNase I or RNase A, and ﬁnally subjected to
immunoﬂuorescence microscopy analysis after staining with
antibodies against sigmaA and nucleophosmine/B23. B23 was
used as a positive control because it is a nucleolar RNA-binding
protein that is removed from the nucleus upon RNase treatment
(Hirano et al., 2009). In untreated ﬁxed cells, sigmaA was
concentrated in the nucleoplasm whereas most B23 was localized
within the nucleolus (Fig. 4B, row 1). The normal subnuclear
distribution of the two proteins was not altered by treating the
cells with DNase, suggesting that they are not DNA binding
proteins (Fig. 4B, row 2). As expected, the nucleolar ﬂuorescence
signal of B23 disappeared from the nucleolus upon treating the
ﬁxed cells with RNase A (Fig. 4B, row 3, middle picture). In
contrast, the normal nucleoplasmic accumulation of sigmaA was
not perturbed by the RNase treatment (Fig. 4B, row 3, left
picture). Taken together, these results suggest that sigmaA
associates with the nuclear matrix of mammalian cells in an
RNA-independent manner.
Inhibition of RNA polymerase II activity induces sigmaA
redistribution to the cytoplasm
The nucleocytoplasmic distribution of a number of proteins is
inﬂuenced by the transcriptional activity of the cell. Some nuclear
proteins migrate to the cytoplasm upon inhibition of transcription
(Pinol-Roma and Dreyfuss, 1991), whereas others require ongoing
RNA polymerase activity for nuclear export (Khacho et al., 2008).To investigate the transcription dependence of nuclear sigmaA
accumulation in mammalian cells, the effect of RNA polymerase
inhibitors was investigated. For this, ARV-infected Vero cells were
treated for 5 h with cycloheximide (20 mg/ml) plus concentrations
of actinomycin D (AMD) that inhibit the activity of RNA poly-
merase I (0.05 mg/ml) and RNA polymerase II (0.5 mg/ml). We ﬁrst
checked the effectiveness of our AMD in Vero cells by showing
that incubation of these cells with 0.05 mg/ml of AMD induces
nucleolus-to-nucleoplasm redistribution of nucleophosmine/B23
(Fig. 5A), a situation similar to that previously reported for mouse
embryonic ﬁbroblasts (Meder et al., 2004). In contrast, sigmaA
remained conﬁned within the nucleoplasm of Vero cells treated
with 0.05 mg/ml of AMD (Fig. 5A and B, row 2), suggesting that
nuclear sigmaA accumulation is not dependent on RNA polymer-
ase I activity. However, nucleus-to-cytoplasm redistribution of
sigmaA took place in more than 80% of infected Vero cells when
incubated in the presence of 0.5 mg of AMD/ml (Fig. 5B, row 3) or
the RNA polymerase II inhibitors a-amanitin and DRB (Fig. 5B,
Fig. 5. Effect of transcription inhibitors on nuclear accumulation. (A) At 14 h.p.i. infected Vero cells were incubated for 5 h at 37 1C with 20 mg of cycloheximide/ml (row 1)
or with cycloheximide plus 0.05 mg of AMD/ml (row 2), and then processed for immunoﬂuorescence. The cells were stained blue with DAPI (right pictures) and
immunostained green for sigmaA (left pictures) and red for nucleophosmine/B23 (middle pictures). (B) At 9 h.p.i. ARV infected Vero cells were incubated for 5 h at 37 1C
with 20 mg of cycloheximide/ml (row 1) plus the concentrations of the inhibitors indicated on the left of rows 2–6. The cells in row 6 were subsequently incubated for
another 5 h in DRB-free medium. The cells in the left pictures were stained green for sigmaA, and in the right pictures were further stained red for ﬁbrillarin and
conterstained blue with DAPI. More than 100 stained cells were counted in the slides of rows 3, 4 and 5, and sigmaA staining was excluded from the nucleus in more of 80%
of the cells. (C) Vero cells were incubated for 3 h with the concentrations of the inhibitors indicated on the left, then permeabilized with digitonin and incubated with MBP-
sigmaA dissolved in transport buffer (left lane) or GNG dissolved in complete transport buffer (right lane). The cells were immunostained green for sigmaA (left pictures)
and visualized by ﬂuorescence microscopy. Black scale bars: 20 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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not however occur when the cells were incubated with cyclohex-
imide alone (Fig. 5B, row 1), indicating that the cytoplasmic
accumulation of this protein is likely the result of transcription
inhibition rather than inhibition of protein synthesis.
DRB-induced cytoplasmic accumulation of sigmaA was
reversed when Vero cells were subsequently incubated in DRB-
free medium (Fig. 5B, row 6), suggesting that ongoing transcrip-
tion is required for sigmaA nuclear import. To test this hypothesis
we performed import assays in Vero cells that had been pre-
incubated for 3 h with different AMD concentrations before
digitonin permeabilization. The results shown in Fig. 5C revealed
that while MBP-sigmaA still reaches the nucleus of permeabilized
cells that had been preincubated with 0.05 mg of AMD/ml (row 2,
left picture), the protein does not enter the nucleus of the cells
that had been preincubated with 0.5 mg of AMD/ml (row 3, left
picture). However, the latter treatment did not prevent GNG from
reaching the nucleus of digitonin-permeabilized Vero cells
(Fig. 5C, left picture of row 3), supporting the notion that
transcription inhibitors do not inhibit nuclear import mediated
by classical NLSs (Pinol-Roma and Dreyfuss, 1991; Stauber et al.,
2001). These results indicate that sigmaA nuclear export and
import are coupled to RNA polymerase II activity.
Inhibition of RNA polymerase II activity promotes sigmaA nuclear
export via a Ran- and CRM1-dependent pathway
We next investigated the mechanism by which sigmaA exits
the nucleus after RNA polymerase II inhibition. As shown in
Fig. 6A, sigmaA redistributes to the cytoplasm when ARV-infected
Vero cells were incubated in the presence of 0.5 mg/ml of AMD at
37 1C (row 2), but not when the incubation was performed at 4 1C
(row 3), indicating that sigmaA nuclear export is a temperature-
dependent process.
It has been reported that cellular ATP depletion induces
a major drop in both free GTP and the nuclear concentration ofRan-GTP, which in turn leads to inhibition of classical nuclear
transport, because a nuclear Ran-GTP pool is required for both the
assembly of export complexes and the disassembly of import
complexes (Schwoebel et al., 2002). To determine whether
sigmaA nuclear export observed upon RNA polymerase II arrest
is a Ran-dependent process, we compared the effect of AMD on
sigmaA localization in ATP-depleted and -nondepleted infected
Vero cells. Incubation of ARV-infected Vero cells for 15 min in the
presence of 10 mM sodium azide and 10 mM deoxyglucose
caused a drop in the intracellular ATP level to 4% of its normal
value (determined with the FLASC Sigma-Aldrich kit), and abol-
ished the capacity of AMD to induce nucleus-to-cytoplasm
sigmaA redistribution (Fig. 6A, compare rows 2 and 4). These
results suggest that, contrary to nuclear import, sigmaA nuclear
export is an energy- and Ran-dependent process.
Chromosome region maintenance 1 (CRM1) is a member of the
importin-b family and a nuclear export receptor for many
different classes of cellular proteins and for speciﬁc RNAs, which
is speciﬁcally and potently inhibited by the antifungal cytotoxin
leptomycin B (LMB) (Kudo et al., 1999). Within the nucleus, CRM1
associates with both Ran-GTP and cargo proteins that possess a
leucine-rich nuclear export signal (NES), and the trimeric complex
crosses the nuclear pore to deliver the cargo protein in the
cytoplasm (Fornerod et al., 1997). To determine whether the
cytoplasmic accumulation of sigmaA observed after RNA poly-
merase II inhibition reﬂects nuclear export through a CRM1-
dependent pathway, we investigated the effect of LMB, both alone
and in the presence of AMD, on the intracellular localization of
ARV proteins sigmaA and p17 in ARV-infected Vero cells. We used
p17 as a control protein because we have previously shown that
AMD induces its nuclear exclusion via a CRM1-independent
pathway (Costas et al., 2005). Infected Vero cells were incubated
for 5 h in culture medium supplemented with 20 mg of cyclohex-
imide/ml plus either: (i) 30 ng of LMB/ml; (ii) 0.5 mg of AMD/ml;
or (iii) 0.5 mg of AMD/ml plus 30 ng of LMB/ml. Most sigmaA and
p17 remained associated to the nucleoplasm when infected cells
Fig. 6. Effect of inhibitors on sigmaA nuclear exit. (A) ARV-infected Vero cells
were incubated for 5 h with cycloheximide (row 1) or with cycloheximide plus
0.5 mg of AMD/ml, at either 37 1C (rows 2 and 4) or 4 1C (row 3). In row 4 the cells
were ATP depleted by incubation with sodium azide and deoxyglucose, starting
15 min before the AMD treatment and during the treatment. The cells were then
ﬁxed, immunostained green for sigmaA (left pictures) and blue with DAPI (right
pictures). These experiments were repeated several times and shown to be
reproducible. (B) ARV-infected Vero cells were incubated for 5 h at 37 1C with
cycloheximide plus the inhibitors shown at the left. The cells were subsequently
ﬁxed, stained blue with DAPI (left pictures) and immunostained green for p17
(middle pictures) and red for sigmaA (right pictures). Black scale bars: 20 mm.
More than 100 stained cells were counted on the slide of row 3 and in 90% of the
cells sigmaA staining was detected within the nucleus. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
Fig. 7. Heterokaryon assay. Semiconﬂuent Vero cell monolayers were co-trans-
fected with pCDNA3.1-sigmaA and pEGFP-p17 plasmids, and 24 h later the cells
were scrapped off the plate. Aliquots of 5105 transfected cells were then fused
with the same amount of untransfected mouse L929 cells in the presence of 50%
polyethylene glycol 4000 plus 100 mg of cycloheximide/ml. At the post-fusion
times indicated at the right, the cells were ﬁxed, stained blue with DAPI (left
pictures) and immunostained red for sigmaA (right pictures). GFP-p17 is stained
green (middle pictures). Cells of two representative experiments are shown for
each time point. White arrows in left pictures point towards acceptor mouse cell
nuclei within heterokaryons. Black scale bar: 20 mm. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
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the antifungal cytotoxin does not alter the normal nuclear
distribution of these proteins. However, LMB was able to block
the capacity of AMD to induce nucleus-to-cytoplasm transloca-
tion of sigmaA in 90% of the antigen-positive cells (Fig. 6B,
compare rows 2 and 3, right pictures), but did not prevent
cytoplasmic accumulation of p17 (Fig. 6B, compare rows 2 and
3, middle pictures). A similar LMB effect was obtained in sigmaA-
transfected cells (result not shown). These data demonstrate that
sigmaA, but not p17, uses a CRM1-dependent pathway to exit the
nucleus upon RNA polymerase II inhibition.
SigmaA does not shuttle between the nuclear and cytoplasmic
compartments
Many nuclear proteins are permanently trapped within the
nucleus, whereas others have the ability to shuttle between the
nucleus and cytoplasm (reviewed in Nigg (1997)). Since manynuclear proteins whose nuclear accumulation is coupled to RNA
polymerase activity are able to recirculate between the nucleus
and the cytoplasm, we examined the nucleocytoplasmic shuttling
properties of ARV protein sigmaA. To accomplish this, we per-
formed an in vivo interspecies heterokaryon assay that has been
used to characterize the shuttling properties of nuclear proteins
(Fan and Steitz, 1998; Inman et al., 2002; Michael et al., 1997),
and that we have successfully used to document the shuttling
activity of the ARV nonstructural p17 protein (Costas et al., 2005).
Monkey Vero cells were co-transfected with the recombinant
plasmids pEGFP-p17 and pCDNA3.1-sigmaA and 24 h later the
cells were fused with untransfected mouse L929 cells in the
presence of 50% polyethylene glycol. The fused cells were then
incubated for different times in the presence of 100 mg of
cycloheximide/ml and processed for immunoﬂuorescence analy-
sis. Monkey and mouse nuclei in heterokaryons can be distin-
guished by Hoechst staining, since monkey nuclei display a
relatively diffuse stain, whereas the nuclei of rodent cells exhibit
a characteristic punctuate pattern due to intranuclear body
staining (Fan and Steitz, 1998). The presence of sigmaA in mouse
nuclei of heterokaryons would indicate that the protein was able
to exit the monkey nuclei and to penetrate into the nuclei of
untransfected mouse cells. The results shown in Fig. 7 revealed
that GFP-associated ﬂuorescence was localized in both monkey
and mouse nuclei of heterokaryons at both 4 and 15 h after cell
fusion (middle pictures), conﬁrming our previous observation
that p17 is a nucleocytoplasmic shuttling protein (Costas et al.,
2005). In clear contrast, sigmaA staining remained conﬁned
exclusively within the Vero cell nuclei at the two times tested
(right pictures), indicating that sigmaA is unable to translocate
from donor-transfected nuclei into recipient mouse nuclei, and
hence that it does not trafﬁc between the nucleus and cytoplasm
of Vero cells.
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In this study we have examined the karyophilic properties of
ARV protein sigmaA in mammalian cells. Our data showed that, as
in avian cells, sigmaA is able to enter the nucleus of mammalian
cells by a nondiffusional energy- and importin-independent
mechanism and that its presence within the nucleus is not
promoted by viral factors or by changes induced by the viral
infection. This is supported by our ﬁndings that sigmaA enters the
nucleus of digitonin-permeabilized cells faster and more efﬁ-
ciently than an NLS-containing protein, and that sigmaA is still
able to reach the nucleus of permeabilized Vero cells when the
import assay was performed in the presence of a 20-fold excess of
competitor GNG.
One striking and interesting ﬁnding of this study is that
sigmaA was detected in the nucleolus of avian cells and in the
nucleoplasm of mammalian cells, suggesting that its nuclear
distribution is controlled by species-speciﬁc factors or by alter-
native posttranslational modiﬁcations. Our ﬁnding that bacte-
rially-expressed MBP-sigmaA is imported into the nucleolus of
avian cells and into the nucleoplasm of mammalian cells suggests
that posttranslational modiﬁcations do not likely play a role in
sigmaA localization. Extraction of digitonin-permeabilized cells
with hypotonic buffer revealed that sigmaA becomes arrested in
the nucleoplasm of mammalian cells by binding to mammalian-
speciﬁc factors, which in turn suggests that the nucleolus is the
normal sigmaA target, and that the viral protein is unable to reach
the nucleolus of mammalian cells because it is anchored to the
nucleoplasm via association with mammalian-speciﬁc factors.
In order to characterize these factors, we are currently trying
to identify sigmaA-interacting proteins that are present in
extracts of Vero cells, but not in those of avian cells, as well as
sigmaA-interacting proteins that are eluted from digitonin-per-
meabilized Vero cells upon extraction with hypotonic buffer.
Distinct subnuclear localization is not the only difference
observed in the intracellular distribution of sigmaA in avian
versus mammalian cells. Our data further showed that, whereas
most sigmaA is present in the cytoplasm of infected avian cells,
only a minor fraction of the viral protein is detected in the
cytoplasm of infected mammalian cells. Since sigmaA is a struc-
tural core protein whose presence in cytoplasmic viral factories is
required to form progeny viral particles, the scarcity of sigmaA in
cytoplasmic inclusions of infected mammalian cells could be one
of the factors that account for the reported lower replication
efﬁciency of ARV in mouse L cells versus avian cells (Mallo et al.,
1991a, b). We have tried to test this hypothesis by examining the
effect of AMD on ARV production in Vero cells, but unfortunately
Vero cells are much more sensitive than L cells to long exposures
to 0.5 mg/ml of the transcriptional inhibitor. To overcome this
problem, we are now performing these experiments in ARV-
infected mouse L cells, although trying to establish a correlation
between the effect that transcription inhibitors exert on virus
production and the intracellular sigmaA distribution is not going
to be an easy task, since inhibition of RNA polymerase II activity
not only induces the accumulation of sigmaA in cytoplasmic viral
factories, but also causes nucleus-to-cytoplasm redistribution of
p17 (Vazquez-Iglesias et al., 2009) and diminished intracellular
levels of cellular mRNAs (Mallo et al., 1991b).
The inhibition of RNA polymerase II activity in ARV-infected
mammalian cells induces sigmaA redistribution to the cytoplasm,
and the effect of LMB on the AMD-induced nuclear export
indicates that sigmaA exits the mammalian cell nucleus via a
canonical CRM1-dependent pathway. This in turn suggest that
sigmaA nuclear export requires RanGTP, since all CRM1-mediated
export requires RanGTP (Fornerod et al., 1997; Fukuda et al.,
1997), and since cellular ATP depletion, which drastically reducesthe nuclear pool of RanGTP (Schwoebel et al., 2002), also impairs
sigmaA nuclear exit. We do not know yet whether sigmaA exits
the nucleus of mammalian cells after AMD treatment by binding
directly to CRM1/RanGTP or whether it uses the nuclear export
signal (NES) of a sigmaA-associated protein to cross the nuclear
pore in a piggy-back fashion. In contrast, inhibition of both RNA
polymerase I and II activities did not avoid nucleolar sigmaA
accumulation in infected avian cells (not shown), suggesting that
the effect of RNA polymerase II inhibitors on sigmaA nuclear exit
in mammalian cells is an indirect effect on sigmaA-associated
proteins. This is supported by our ﬁndings that sigmaA does not
recirculate between the nucleus and the cytoplasm of transcrip-
tion-competent mammalian cells and that sigmaA is retained in
the nucleoplasm of mammalian cells by association with mam-
malian-speciﬁc factors. Inhibition of transcription, which induces
the reorganization of many subnuclear compartments and the
proteins that form them (Dundr and Misteli, 2001), could release
the masked CRM1-dependent NES of a sigmaA-associated protein,
thus allowing sigmaA to exit the nucleus in a piggy-back fashion,
as has been reported for other proteins (Foo et al., 2007; Hamilton
et al., 1997; Li et al., 2008).
To our knowledge only two viral proteins have been previously
reported to display different localization in mammalian versus
avian cells. Similar to the sigmaA situation, the NS1 protein of
certain strains of inﬂuenza A virus accumulate in the nucleoplasm
of mammalian cells and in the nucleolus of avian cells (Volmer
et al., 2010). On the other hand, protein 3b of infectious bronchitis
virus (IBV) has been shown to localize to the nucleus when
transiently-expressed in vaccinia virus-infected mammalian cells,
but to the cytoplasm of both IBV-infected and transfected avian
cells (Pendleton and Machamer, 2006). The results of this study
and the ones presented in this manuscript highlight the impor-
tance of using cells derived from the natural host when analyzing
molecular aspects of viral replication and when studying the
properties of viral proteins. Accordingly, the conclusions reached
by studying the replication of ARVs in mammalian cells should be
taken with caution, unless the results are reproduced in
avian cells.Materials and methods
Cells, viruses, antibodies, plasmids and reagents
Primary cultures of CEF were prepared from 9- to 10-day old
chicken embryos and grown in medium 199 supplemented with
10% tryptose phosphate broth and 5% calf serum. Strain 1733 of
ARV was grown on semiconﬂuent monolayers of primary CEF as
previously described (Grande and Benavente, 2000). Chicken DF1,
monkey Vero, mouse L929 and human HeLa cells were grown in
monolayers in medium DMEM supplemented with 10% fetal
bovine serum.
The generation of monoclonal and polyclonal antibodies
against sigmaA and muNS has been described (Martinez-Costas
et al., 2000; Tourı´s-Otero et al., 2004). Anti-ﬁbrillarin (mouse
monoclonal, clone AFBN01) was purchased from Cytoskeleton,
Inc. (Denver, Col.). Anti-B23 (mouse monoclonal, clone FC-8791)
and anti-histone H1 (mouse monoclonal, clone AE-4) were from
Santa Cruz Biotechnology Inc. (Heidelberg, Germany), and anti-
GFP was from Roche (Barcelona, Spain). Alexa Fluor 594 goat anti-
mouse (red; #A11005) Alexa Fluor 594 goat anti-rabbit (red;
#A11012), Alexa Fluor 488 goat anti-mouse (green; #A11001),
and Alexa-Fluor 488 goat anti-rabbit (green; #A11008) ﬂuores-
cent-conjugated secondary antibodies were purchased from Invi-
trogen (Barcelona, Spain).
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sion of MBP-sigmaA), pEGFP-sigmaA (for eukaryotic expression of
GFP-sigmaA), pCDNA3.1-sigmaA (for eukaryotic expression of
full-length sigmaA), pEGFP-p17 (for eukaryotic expression of
GFP-p17) has been previously described (Costas et al., 2005;
Vazquez-Iglesias et al., 2009). The plasmid for bacterial expres-
sion of GST–NLS–GFP (GNG) has been reported (Miyamoto et al.,
2002; Yokoya et al., 1999). Digitonin, WGA and Mowiol were
purchased from Calbiochem (Darmstadt, Germany). All other
reagents used in this study were from Sigma-Aldrich.Infections, transfections, heterokaryon formation and ﬂuorescence
microscopy
Infection of avian and mammalian cells by ARV has been
described (Grande and Benavente, 2000). Transfections of cell
monolayers were done with Lipofectamine (Invitrogen), accord-
ing to the manufacturer’s instructions. Transfected cells were
incubated at 37 1C for 24 h, unless otherwise stated. For ATP
depletion, cell monolayers were incubated for 15 min in PBS
containing 10% fetal bovine serum, 10 mM sodium azide and
10 mM 2-deoxyglucose (Schwoebel et al., 2002). ATP-depleted
cells were subsequently incubated for the indicated times in
the same medium supplemented with 5 mg of actinomycin
D (AMD)/ml.
For heterokaryon assays, Vero cell monolayers were co-trans-
fected with plasmids expressing GFP-p17 and sigmaA, and 24 h
later the cells were detached by trypsinization, placed on cover-
slips and incubated for 15 h at 37 1C. Heterokaryons were gener-
ated by fusing transfected Vero cells with untransfected mouse
L929 cells in the presence of 50% polyethylene glycol. The fused
cells were incubated for different times in the presence of 100 mg
of cycloheximide/ml as previously described (Costas et al., 2005;
Fan and Steitz, 1998).
For indirect immunoﬂuorescence microscopy, cell monolayers
were grown on coverslips and infected or transfected. At the
indicated times, monolayers were washed twice with PBS and
ﬁxed either for 10 min at room temperature in 4% paraformalde-
hyde in PBS, or for 15 min at 20 1C in 100% methanol. Paraf-
ormaldehyde-ﬁxed cells were washed twice with PBS, incubated
for 3 min in permeabilizing buffer (0.5% Triton X-100 in PBS) and
then blocked in PBS containing 2% bovine serum albumin for
30 min at room temperature. Methanol-ﬁxed cells were washed
twice with PBS and blocked for 30 min at room temperature in
PBS containing 2% bovine serum albumin. All ﬁxed cells were
incubated for 1 h at room temperature with primary antibodies
diluted in blocking buffer. After three washes with PBS, the cells
were incubated for 30 min with secondary antibodies and DAPI.
Cell-containing coverslips were then washed six times with PBS
and mounted on glass slides. Images were obtained with an
Olympus DP-71 digital camera mounted on an Olympus BX51
ﬂuorescence microscope. Images were processed with Adobe
Photoshop (Adobe Systems, California, USA).Bacterial expression and puriﬁcation of recombinant proteins, and
import assays
The expression and puriﬁcation of MBP-sigmaA, sigmaA and
GNG have been described (Guardado-Calvo et al., 2008; Hermo-
Parrado et al., 2007; Miyamoto et al., 2002; Yokoya et al., 1999).
Preparation of cytosolic extracts, digitonin permeabilization and
import assays all were performed as described previously
(Vazquez-Iglesias et al., 2009).Nuclease treatment and nuclear matrix preparation
For nuclease treatment, monolayers of ARV-infected Vero cells
growing on coverslips were ﬁxed for 2 min in methanol at
20 1C, rinsed with PBS and incubated with either RNase A
(100 mg/ml in PBS) or DNase I (40 U/ml in PBS supplemented
with 5 mM MgCl2) for 2 h at room temperature (Hirano et al.,
2009). Cells were then washed several times with PBS and
processed for immunoﬂuorescence.
Nuclear matrix preparation was performed essentially as
previously described (Tang et al., 1998). Infected Vero cells
growing on coverslips were washed with cold PBS and extracted
with CSK buffer (10 mM PIPES-NaOH pH 6.8, 100 mM NaCl,
300 mM sucrose, 3 mM MgCl2, 1 mM EGTA, and 0.5% Triton
X-100) for 5 min at 4 1C. The buffer was then removed and the
cells were incubated in DNase buffer (10 mM PIPES-NaOH pH 6.8,
50 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 0.5% Triton X-100,
and 40 U of RNase-free DNase I/ml) for 1 h at 37 1C. Nuclease-
treated cells were sequentially extracted with 0.25 M ammonium
sulphate in CSK buffer for 5 min at room temperature, and then
with 2 M NaCl in CSK buffer. Cell monolayers were ﬁxed after
each extraction step and processed for immunoﬂuorescence.Acknowledgments
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